Longeveron(LGVN) - 2025 Q1 - Quarterly Results

Exhibit 99.1 Longeveron® Announces First Quarter 2025 Financial Results and Provides Business Update MIAMI, May 8, 2025 -- Longeveron Inc. (NASDAQ: LGVN), a clinical stage regenerative medicine biotechnology company developing cellular therapies for life-threatening and chronic aging-related conditions, today reported financial results for the quarter ended March 31, 2025 and provided a business update. "In the first quarter, we made notable progress advancing the development of our stem cell therapy, larom ...